已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Three-Dimensional Conformal Radiation Therapy and Intensity-Modulated Radiation Therapy Combined With Transcatheter Arterial Chemoembolization for Locally Advanced Hepatocellular Carcinoma: An Irradiation Dose Escalation Study

医学 肝细胞癌 毒性 放射治疗 急性毒性 经导管动脉化疗栓塞 队列 核医学 立体定向放射治疗 内科学 放射科 胃肠病学 肿瘤科 放射外科
作者
Zhi-Gang Ren,Jian-Dong Zhao,Ke Gu,Zhen Chen,Jun-Hua Lin,Zhi-Yong Xu,Wei-Gang Hu,Zhen-Hua Zhou,Lu-Ming Liu,Guo-Liang Jiang
出处
期刊:International Journal of Radiation Oncology Biology Physics [Elsevier BV]
卷期号:79 (2): 496-502 被引量:27
标识
DOI:10.1016/j.ijrobp.2009.10.070
摘要

Purpose To determine the maximum tolerated dose (MTD) of three-dimensional conformal radiation therapy (3DCRT)/intensity-modulated radiation therapy (IMRT) combined with transcatheter arterial chemoembolization for locally advanced hepatocellular carcinoma. Methods and Materials Patients were assigned to two subgroups based on tumor diameter: Group 1 had tumors <10 cm; Group II had tumors ≥10 cm. Escalation was achieved by increments of 4.0 Gy for each cohort in both groups. Dose-limiting toxicity (DLT) was defined as a grade of ≥3 acute liver or gastrointestinal toxicity or any grade 5 acute toxicity in other organs at risk or radiation-induced liver disease. The dose escalation would be terminated when ≥2 of 8 patients in a cohort experienced DLT. Results From April 2005 to May 2008, 40 patients were enrolled. In Group I, 11 patients had grade ≤2 acute treatment-related toxicities, and no patient experienced DLT; and in Group II, 10 patients had grade ≤2 acute toxicity, and 1 patient in the group receiving 52 Gy developed radiation-induced liver disease. MTD was 62 Gy for Group I and 52 Gy for Group II. In-field progression-free and local progression-free rates were 100% and 69% at 1 year, and 93% and 44% at 2 years, respectively. Distant metastasis rates were 6% at 1 year and 15% at 2 years. Overall survival rates for 1-year and 2-years were 72% and 62%, respectively. Conclusions The irradiation dose was safely escalated in hepatocellular carcinoma patients by using 3DCRT/IMRT with an active breathing coordinator. MTD was 62 Gy and 52 Gy for patients with tumor diameters of <10 cm and ≥10 cm, respectively. To determine the maximum tolerated dose (MTD) of three-dimensional conformal radiation therapy (3DCRT)/intensity-modulated radiation therapy (IMRT) combined with transcatheter arterial chemoembolization for locally advanced hepatocellular carcinoma. Patients were assigned to two subgroups based on tumor diameter: Group 1 had tumors <10 cm; Group II had tumors ≥10 cm. Escalation was achieved by increments of 4.0 Gy for each cohort in both groups. Dose-limiting toxicity (DLT) was defined as a grade of ≥3 acute liver or gastrointestinal toxicity or any grade 5 acute toxicity in other organs at risk or radiation-induced liver disease. The dose escalation would be terminated when ≥2 of 8 patients in a cohort experienced DLT. From April 2005 to May 2008, 40 patients were enrolled. In Group I, 11 patients had grade ≤2 acute treatment-related toxicities, and no patient experienced DLT; and in Group II, 10 patients had grade ≤2 acute toxicity, and 1 patient in the group receiving 52 Gy developed radiation-induced liver disease. MTD was 62 Gy for Group I and 52 Gy for Group II. In-field progression-free and local progression-free rates were 100% and 69% at 1 year, and 93% and 44% at 2 years, respectively. Distant metastasis rates were 6% at 1 year and 15% at 2 years. Overall survival rates for 1-year and 2-years were 72% and 62%, respectively. The irradiation dose was safely escalated in hepatocellular carcinoma patients by using 3DCRT/IMRT with an active breathing coordinator. MTD was 62 Gy and 52 Gy for patients with tumor diameters of <10 cm and ≥10 cm, respectively.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
耷拉地啦完成签到,获得积分10
刚刚
初昀杭完成签到 ,获得积分10
5秒前
晓书完成签到 ,获得积分10
6秒前
13秒前
Ultraman45发布了新的文献求助10
13秒前
JamesPei应助林佳一采纳,获得10
14秒前
科研小白完成签到 ,获得积分10
14秒前
正直蜗牛完成签到,获得积分10
14秒前
Akim应助白日梦采纳,获得10
15秒前
17秒前
小澜孩完成签到,获得积分10
17秒前
小澜孩发布了新的文献求助10
20秒前
24秒前
科目三应助彼岸花开采纳,获得50
25秒前
27秒前
白日梦发布了新的文献求助10
31秒前
cy0824完成签到 ,获得积分10
33秒前
Omni完成签到,获得积分10
36秒前
胡图图啦啦完成签到 ,获得积分10
38秒前
白日梦完成签到,获得积分10
38秒前
斜阳完成签到 ,获得积分10
42秒前
2333完成签到 ,获得积分10
42秒前
量子星尘发布了新的文献求助10
47秒前
爆米花应助懂得瞧采纳,获得10
49秒前
mini完成签到 ,获得积分10
50秒前
健壮惋清完成签到 ,获得积分10
51秒前
机灵的听云完成签到,获得积分20
51秒前
xiao完成签到 ,获得积分10
51秒前
鹿靡完成签到,获得积分10
1分钟前
挤爆沙丁鱼完成签到,获得积分10
1分钟前
lf发布了新的文献求助10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
科研通AI5应助科研通管家采纳,获得10
1分钟前
完美世界应助科研通管家采纳,获得10
1分钟前
1分钟前
1分钟前
mmyhn完成签到,获得积分10
1分钟前
懂得瞧发布了新的文献求助10
1分钟前
1分钟前
大个应助研友_Zzy1pn采纳,获得10
1分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976600
求助须知:如何正确求助?哪些是违规求助? 3520689
关于积分的说明 11204470
捐赠科研通 3257316
什么是DOI,文献DOI怎么找? 1798683
邀请新用户注册赠送积分活动 877881
科研通“疑难数据库(出版商)”最低求助积分说明 806613